Vichy launches online game, app inspired by its CelluDestock skin-firming cream
NEW YORK — Vichy Labs — which sells its products at select CVS/pharmacy, Duane Reade, Walgreens and Ulta locations — has rolled out a new digital initiative inspired by its CelluDestock skin-firming and anti-cellulite product.
“Booty Break” has launched across all digital platforms with a special site and complementary content on YouTube, mobile and social media. The website, Bootybreak.com, leads visitors to share, discover and download brawny bottoms of all shapes and sizes with a variety of ways to “shake your booty.”
Viewers can scroll through an array of robust rear ends ranging from sporty and corporate to preppy and trendy with the option to have each gluteus maximus “slap,” “shake,” “dance” or “flex” to the tune of “Baby, Baby, Baby” by Make the Girl Dance.
After the initial “Booty Break,” the brand offers a “booty-loving” app with exercise tips from a fitness trainer, as well as an array of abdominal and gluteal exercises in 30-second vignettes. The campaign also provides an exclusive offer for women to try Vichy’s CelluDestock, the skin-firming cream designed to reduce the appearance of cellulite by smoothing and toning the ski.
To create the “Booty Break” video and mobile app, Vichy teamed up with the Montreal-based digital firm Tuxedo Agency to create the playful digital platforms. They enlisted the help of eight “guys next door” who showed off their assets for the interactive website, and the complementary mobile app, which offers a unique motivation to promote a healthy lifestyle. It features a trainer demonstrating easy exercise moves and allows users to learn about Vichy’s body care products, chart their progress and earn rewards for a job well done.
“Our goal for the “Booty Break” campaign is to provide a provocative and engaging way to get women talking about their bodies in a positive way,” stated Marianna Trofimova, VP marketing for Vichy Laboratories. “But we also give them practical tips and complementary products to help them make the most of what they have. We want women to love the results and to love their booty.”
AmerisourceBergen promotes finance executive to corporate controller
VALLEY FORGE, Pa. — AmerisourceBergen on Friday announced that Lazarus Krikorian has been named VP, corporate controller, effective immediately.
Krikorian will be an officer of the company and will report to Tim Guttman, who was recently appointed SVP and CFO, and whom Krikorian succeeds as corporate controller.
"[Laz] is a seasoned financial executive who has demonstrated excellent leadership, including playing a key role in the successful implementation of our new back-office ERP platform," Guttman said. "Laz is also responsible for overseeing the company’s internal and external financial reporting process."
Krikorian was previously VP assistant corporate controller, a position he held since joining AmerisourceBergen in 2002. Prior to joining ABC, he held other financial management positions, including senior assurance manager at KPMG LLP.
Krikorian holds a bachelor of science in the dual major of accounting and finance from Drexel University.
House restores OTC reimbursements under FSAs; bill passes to Senate
WASHINGTON — The House of Representatives on Thursday passed the Protect Medical Innovation Act of 2012 by a vote of 270-to-146, which will reinstate over-the-counter medicines as eligible expenses under flexible spending accounts without the requisite prescription established by the Patient Protection and Affordable Care Act last year.
"By reinstating the ability of Americans to use their flexible spending accounts for over-the-counter medication and by making it possible for them to reclaim their unused money, we are making it easier for Americans to be in charge of both their health care and their finances," said Rep. Tim Huelskamp, R-Kan., who co-sponsored the legislation.
The repeal language included in the bill is from the Restoring Access to Medication Act (H.R. 5842), introduced by Rep. Lynn Jenkins, R-Kan., which was approved by the House Ways and Means Committee last week.
The bill now heads to the Senate next for consideration.
The passage of the bill received praise from industry leaders, including the Consumer Healthcare Products Association.
"The House of Representatives’ vote [today] is a win for America’s tax-payers who use health savings accounts to manage their family’s healthcare costs," CHPA president and CEO Scott Melville in a release issued late Thursday. "How an individual or family chooses to spend the dollars they set aside in a flexible spending arrangement should be based on their healthcare needs and not hindered by a policy that does more to reduce healthcare access than expand it."